Schizophrenia and Psychoses Feature Archive

Secondary Outcome Bias Prevalent in Antipsychotic Randomized Controlled Trials

Secondary Outcome Bias Prevalent in Antipsychotic Randomized Controlled Trials

Understanding more about the original protocols of RCTs for various drugs may offer helpful insights into the clinical implications of those trials' findings.

Art Therapy as an Intervention for Psychosis

Art Therapy as an Intervention for Psychosis

A patient does not have to be verbal to benefit from art therapy.

Psychiatric Care for Incarcerated Patients

Psychiatric Care for Incarcerated Patients

According to one review, there are more individuals with serious mental illness in correctional institutions than in all US state hospitals.

Which Came First, the Cigarette or the Psychiatric Diagnosis?

Which Came First, the Cigarette or the Psychiatric Diagnosis?

University of Washington Tobacco Scholar Joseph Cerimele, MD, MPH, discusses the relationship between smoking and psychiatric illness.

Current Status of Clinical Practice Guidelines in Schizophrenia

Current Status of Clinical Practice Guidelines in Schizophrenia

The methodological quality of schizophrenia guidelines varies, while lack of consistency across guidelines and inadequate adherence in the clinical setting can impact the quality of care and outcome.

Taking Psychosis Therapy Into the Digital Age

Taking Psychosis Therapy Into the Digital Age

SlowMo, a new digital platform for patients to use outside therapy session, targets the psychological processes that play a role in paranoia.

Viewing Psychosis as a Spectrum Can Improve Treatment

Viewing Psychosis as a Spectrum Can Improve Treatment

If psychosis is viewed as a spectrum or a continuum, it becomes easier to identify those at acute end of the spectrum.

An Overview of Psychotic Disorders and Treatment

An Overview of Psychotic Disorders and Treatment

Antipsychotics have been effective in the treatment of psychotic disorders, but clinicians must be cognizant of side effects.

The Underuse of Clozapine in Schizophrenia

The Underuse of Clozapine in Schizophrenia

Although clozapine is often ignored by many clinicians, the antipsychotic should be considered for more patients.

Targeting Common Parasite Could Help Treat Certain Mental Disorders

Targeting Common Parasite Could Help Treat Certain Mental Disorders

Toxoplasma gondii has been implicated in mental illnesses, including schizophrenia and bipolar disorder.

Cannabis and Schizophrenia: Trigger or Treatment?

Cannabis and Schizophrenia: Trigger or Treatment?

While some argue that cannabis may worsen schizophrenia symptoms, evidence is mounting for marijuana as a potential treatment.

The Scott Panetti Case: Why Executing Mentally Ill Prisoners is Unjust

The Scott Panetti Case: Why Executing Mentally Ill Prisoners is Unjust

The case of Scott Panetti, a schizophrenic who killed two people, highlights why mental illness needs to be taken into account with the death penalty.

Avoiding Antipsychotic Polypharmacy in Schizophrenia

Avoiding Antipsychotic Polypharmacy in Schizophrenia

Providers and patients may see better outcomes with simplified regimens.

In the Pipeline: Agents for Schizophrenia and Mood Disorders

In the Pipeline: Agents for Schizophrenia and Mood Disorders

New drugs in development target novel receptors in the brain and modified formulations of existing medications could improve adherence.

Personalized Schizophrenia Treatment Possible with Genomic Testing

Personalized Schizophrenia Treatment Possible with Genomic Testing

Greater use of pharmacogenomic tests could maximize medication efficacy for individual patients.

Consider Patient Preference when Prescribing Antipsychotics for Schizophrenia

Consider Patient Preference when Prescribing Antipsychotics for Schizophrenia

Patient preference, tolerance and efficacy should be considered to achieve optimal therapeutic results.

Sign Up for Free e-newsletters